期刊文献+

不同浓度阿米替林抗大鼠坐骨神经痛觉过敏的实验研究 被引量:2

PERIPHERAL ANTI-HYPERALGESIC EFFECT OF AMITRIPTYLINE FOR SCIATIC NERVE BLOCKADE ON NEUROPATHIC PAIN OF RATS
下载PDF
导出
摘要 目的观察坐骨神经局部注射阿米替林对坐骨神经慢性结扎损伤(chronic constriction injury,CCI)大鼠机械和热痛阈的影响,探讨不同浓度阿米替林外周抗痛觉过敏的作用。方法健康成年雄性SD大鼠53只,体重(200±20)g,按照Bennett等的方法制备CCI模型。取模型制备成功的48只大鼠随机分为6组(n=8):NS组、A2.5组、A5组、A10组、A15.9组和Aip组。Aip组为腹腔注射阿米替林2.5mg,NS组、A2.5组、A5组、A10组和A15.9组分别于坐骨神经旁注射生理盐水0.5mL以及2.5、5.0、10.0、15.9mmol/L阿米替林0.5mL。分别于注药前及注药后1、2、4、8、12、24、48h测定大鼠机械刺激缩足反射阈值(mechanical withdrawal threshold,MWT)和热缩腿反射潜伏期(thermal withdrawal latency,TWL),并根据Hwang等运动评分进行患肢运动功能评价。结果48只大鼠均存活至实验完成,无伤口感染、肢体瘫痪及导管脱落等现象发生。A2.5组、NS组和Aip组大鼠运动功能均无明显改变,运动功能评分3组间比较差异无统计学意义(P>0.05);A5组在2h内、A10组在4h内、A15.9组在8h内均出现运动功能障碍,运动功能评分与NS组、Aip组及注药前比较,差异均有统计学意义(P<0.05);但其后运动功能均完全恢复。注药前6组大鼠MWT和TWL组间比较差异无统计学意义(P>0.05);A2.5组在2h内,A5组在4h内,A10组和A15.9组在24h内各时间点MWT及TWL较注药前、NS组和Aip组均显著升高(P<0.05),且A2.5组、A5组、A10组随阿米替林给药浓度的增加,MWT和TWL逐渐升高,持续时间逐渐延长。A15.9组与A10组间及Aip组与NS组间注药后各时间点MWT及TWL比较差异无统计学意义(P>0.05)。结论坐骨神经旁注射不同浓度(2.5~15.9mmol/L)阿米替林均可提高神经病理性疼痛大鼠的MWT和TWL,具有外周抗痛觉过敏的作用,且有浓度依赖性和封顶效应;5.0~15.9mmol/L阿米替林可产生运动阻滞,但均可完全恢复。 Objective To investigate whether the peripheral administration of hyperalgesic effect following the chronic constriction injury (CCI) of the sciatic nerve in rats amitriptyline produces anti-Methods Forty-eight male CCI rats weighing (220±20) g were randomly divided into 6 groups (n=8): group NS, group A2.5, group A5, group A10, group A15.9 and group Aip. In the group NS, group A2.5, group A5, group A10 and group A15.9, sciatic nerve blockade was locally performed with 0.5 mL normal saline, and 2.5, 5.0, 10.0, 15.9 mmol/L amitriptyline respectively through implanted cannulas on the 7th day after operation. In the group Aip, amitriptyline (2.5 mg) was administered by intraperitoneal injection. The mechanical withdrawal threshold (MWT), thermal withdrawal latency (TWL) and motor function were measured before and 1, 2, 4, 8, 12, 24 and 48 hours after sciatic nerve blockade. Results Forty-eight CCI rats were all survival without infection, palsy and catheter falling off. The rats of group A2.5, group NS and group Aip didn't produce ambulation deficits. There were no significant difference in these 3 groups (P 〉 0.05). However compared with group A2.5, group NS and group Aip, the rats of group A5, group A10, group A15.9 all produced significant ambulation deficits (P 〈 0.05). The ambulation deficits lasted 2 hours (group A5), 4 hours (group A10), 8 hours (group A159) respectively. But the ambulation deficits of CCI rats were all reversible. The MWT and TWL of groups with local injection of amitriptyline increased when conpared with group NS, group Aip and those of before injection (P 〈 0.05). Sciatic nerve blockade with amitriptyline significantly suppressed mechanical hyperalgesia and thermal hyperalgesia in neuropathic rats. The peripheral anti-hyperalgesic effects lasted 2 hours (A2.5 group), 4 hours (group A5), 24 hours (group A10), 24 hours (group A15.9) respectively. But there were no significant difference between A10 group and A15.9 group (P 〉 0.05). There were no significant difference between group NS and group Aip (P 〉 0.05). Conclusion The peripheral anti-hyperalgesic effects can be found in sciatic nerve blockade of amitriptyline on CCI rats. And this effect of amitriptyline has concentration dependent and ceiling effect. Amitriptyline of 5.0-15.9 mmol/L can produce significant ambulation deficits which are reversible.
出处 《中国修复重建外科杂志》 CAS CSCD 北大核心 2008年第11期1339-1343,共5页 Chinese Journal of Reparative and Reconstructive Surgery
关键词 阿米替林 慢性结扎损伤模型 机械痛阈 抗痛觉过敏 Amitriptyline Chronic constriction injury model Neuropathic pain Anti-hyperalgesia
  • 相关文献

参考文献21

  • 1Ashina S, Bendtsen L, Jensen R. Analgesic effect of amitriptyline in chronic tension-type headache is not directly related to serotonin reuptake inhibition, Pain, 2004, 108(1-2): 108-114.
  • 2Pomahac B, Zuhaili B, Kudsi Y, et al. Safety evaluation of topically applied amitri ptyline in porcine full-thickness wounds. Reg Anesth Pain Med, 2007, 32(5): 377-381.
  • 3Sudoh Y, Desai SP, Haderer AE, et al. Neurologic and histopathologic evaluation after high-volume intrathecal amitriptyline. Reg Anesth Pain Med, 2004, 29(5): 434-440.
  • 4Millecamps M, Coderre TJ. Rats with chronic post-ischemia pain exhibit an analgesic sensitivity profile similar to human patients with complex regional pain syndrome--type I. Eur J Pharmacol, 2008, 583(1): 97-102.
  • 5McCarson KE, Ralya A, Reisman SA, et al. Amitriptyline prevents thermal hyperalgesia and modifications in rat spinal cord GABA(B) receptor expression and function in an animal model of neuropathic pain. Biochemical Pharmacol, 2005, 71 ( 1-2): 196-202.
  • 6Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain, 1988, 33(1): 87-107.
  • 7Hwang JH, Yaksh TL. The effect of spinal GABA receptor agnonists on tactile allodynia in a surgically-induced neuropathic pain model in the rat. Pain, 1997, 70(1): 15-22.
  • 8Hall GC, Carroll D, Parry D, et al. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain, 2006, 122(1-2): 156-162.
  • 9Beyreuther B, Callizot N, Stuhr T. Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy. Eur J Pharmacol, 2006, 539( 1-2): 64-70.
  • 10Rintala DH, Holmes SA, Courtade D, et al. Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury. Arch Phys Med Rehabil, 2007, 88(12): 1547-1560.

同被引文献22

  • 1Woolf CJ. Dissecting out mechanisms responsible for peripheral neuropathic pain: implication for diagnosis and therapy. Life Sci, 2004, 74(21): 2605-2610.
  • 2Attal N, Cruccu G, Haanpaa M, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol, 2006, 13(11): 1153-1169.
  • 3Chen YW, Huang KL, Liu SY, et al. Intrathecal tri-cyclic antidepressants produce spinal anesthesia. Pain, 2004, 112(1-2): 106-112.
  • 4Haderer A, Gerner P, Kao G, et al. Cutaneous analgesia after transdermal application of amitriptyline versus lidocaine in rats. AnesthAnalg, 2003, 96(6): 1707-1710.
  • 5Lynch ME, Clark AJ, Sawynok J, et al. Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study. J Pain, 2005, 6(10): 644-649.
  • 6Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain, 1988, 33(1): 87-107.
  • 7Hwang JH, Yaksh TL. The effect of spinal GABA receptor agnonists on tactile allodynia in a surgically-induced neuropathic pain model in the rat. Pain, 1997, 70(1): 15-22.
  • 8Estebe JP, Myers RR. Amitriptyl ine neurotoxicity: dose-related pathology after topical application to rat sciatic nerve. Anesthesiology, 2004, 100(6): 1519-1525.
  • 9Hall GC, Carroll D, Parry D, et al. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain, 2006, 122(1-2): 156-162.
  • 10Pomahac B, Zuhaili B, Kudsi Y, et al. Safety evaluation of topically applied amitriptyline in porcine full-thickness wounds. Reg Anesth Pain Med, 2007, 32(5): 377-381.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部